EUDA Health Holdings Ltd (EUDA)
2.53
+0.11
(+4.55%)
USD |
NASDAQ |
May 31, 16:00
2.56
+0.03
(+1.19%)
After-Hours: 20:00
EUDA Health Holdings Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 91.68M |
| May 30, 2024 | 87.81M |
| May 29, 2024 | 95.89M |
| May 28, 2024 | 99.40M |
| May 24, 2024 | 84.83M |
| May 23, 2024 | 85.35M |
| May 22, 2024 | 85.00M |
| May 21, 2024 | 85.00M |
| May 20, 2024 | 84.30M |
| May 17, 2024 | 84.65M |
| May 16, 2024 | 83.60M |
| May 15, 2024 | 85.00M |
| May 14, 2024 | 84.30M |
| May 13, 2024 | 85.35M |
| May 10, 2024 | 80.79M |
| May 09, 2024 | 67.79M |
| May 08, 2024 | 72.00M |
| May 07, 2024 | 46.78M |
| May 06, 2024 | 50.29M |
| May 03, 2024 | 47.78M |
| May 02, 2024 | 50.04M |
| May 01, 2024 | 49.10M |
| April 30, 2024 | 49.84M |
| April 29, 2024 | 46.64M |
| April 26, 2024 | 51.07M |
| Date | Value |
|---|---|
| April 25, 2024 | 47.63M |
| April 24, 2024 | 47.13M |
| April 23, 2024 | 49.60M |
| April 22, 2024 | 45.41M |
| April 19, 2024 | 45.90M |
| April 18, 2024 | 44.42M |
| April 17, 2024 | 44.42M |
| April 16, 2024 | 47.38M |
| April 15, 2024 | 45.21M |
| April 12, 2024 | 48.86M |
| April 11, 2024 | 49.35M |
| April 10, 2024 | 48.12M |
| April 09, 2024 | 45.90M |
| April 08, 2024 | 45.66M |
| April 05, 2024 | 45.66M |
| April 04, 2024 | 46.39M |
| April 03, 2024 | 47.13M |
| April 02, 2024 | 47.99M |
| April 01, 2024 | 47.87M |
| March 28, 2024 | 47.13M |
| March 27, 2024 | 47.13M |
| March 26, 2024 | 47.13M |
| March 25, 2024 | 48.36M |
| March 22, 2024 | 49.84M |
| March 21, 2024 | 48.12M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
15.21M
Minimum
Jul 18 2023
99.40M
Maximum
May 28 2024
38.74M
Average
37.00M
Median
Dec 15 2022
Enterprise Value Benchmarks
| Haw Par Corp Ltd | -853.06M |
| WAVE Life Sciences Ltd | 575.88M |
| ASLAN Pharmaceuticals Ltd | 17.82M |
| CytoMed Therapeutics Ltd | 18.45M |
| Mobile-health Network Solutions | 45.39M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.100M |
| Revenue (Quarterly) | 1.107M |
| Total Expenses (Quarterly) | 3.040M |
| EPS Diluted (Quarterly) | -0.2462 |